Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.

Source:http://linkedlifedata.com/resource/pubmed/id/20491477

J. Med. Chem. 2010 Jun 24 53 12 4603-14

Download in:

View as

General Info

PMID
20491477